Bio-Techne (TECH) Dividend Coverage Ratio Growth (1y) (2010 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) Dividend Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn | -10.85% |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | - |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - | -1.84% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 178.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 178.74% |
| Mar 31, 2026 | 127.11% |
| Dec 31, 2025 | 11.26% |
| Sep 30, 2025 | 15.87% |
| Jun 30, 2025 | -16,531.75% |
| Mar 31, 2025 | -53.96% |
| Dec 31, 2024 | 25.27% |
| Sep 30, 2024 | -34.29% |
| Jun 30, 2024 | -99.07% |
| Mar 31, 2024 | -30.12% |
| Dec 31, 2023 | -45.07% |
| Sep 30, 2023 | -43.66% |
| Jun 30, 2023 | -26.55% |
| Mar 31, 2023 | 16.70% |
| Dec 31, 2022 | -30.52% |
| Sep 30, 2022 | 29.55% |
| Jun 30, 2022 | 559.76% |
| Mar 31, 2022 | 31.09% |
| Dec 31, 2021 | 53.88% |
| Sep 30, 2021 | 103.97% |